Slowly But Surely | GenomeWeb

Slowly But Surely

Premium

A few months ago, I headed to Washington, DC, for a forum put on by the Genetics and Public Policy Center, a group affiliated with Johns Hopkins and headed up by Kathy Hudson. The topic was "personal genomes, personal health" — and the consensus of the panel session was that while it's still early days for personalized medicine, it's getting increasingly urgent to figure out how patients will react to it and what some best practices may be.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.